Category Archives: Coronary Heart Diseases

When youre facing down cancer, heart disease isnt top of mind. Yet, it turns out many cancer patients face a greater risk from cardiovascular disease (CVD) than from their cancer Continue reading →

by Dr. B Continue reading →

Tap to listen to this article instead: Listen to Post While none of us likes to think of our own mortality or death, we all know that its inevitable. So do take care of your health! In case you didnt know, these are the top five death causes in Malaysia in 2018 based on the Department of Statistics Malaysia (DOSM). 1. Continue reading →

An American biotech company has launched clinical trials in Colombia to test a new therapy designed to reverse the aging process, and in turn, treat age-related diseases, according to news reports. But to steal a sip from this purported fountain of youth, participants in the trial must first fork over $1 million a fee that seems even more astronomical when you consider that most clinical trials are either free or provide participants with financial compensation, according to a report by OneZero, a Medium publication about tech and science. The pricey trial is being run by Libella Gene Therapeutics, a Kansas-based company whose website proclaims that "the future is here." The company announced its intention to test its anti-aging remedies in Cartagena, Colombia, in 2018, and began recruiting for the trials in October of this year Continue reading →

Dr. Nikhil Mahajan Congestive heart failure (CHF) is a chronic progressive condition that affects the pumping power of your heart muscles. Continue reading →

Novel treatment approach revolutionizes the management of cardiovascular disease in the UAE Cardiovascular diseases contribute to 40% of total adult mortality within the UAE Arterial diseases are of particular concern, as they can be asymptomatic but have devastating effects on patients and the healthcare system, underlining the need for novel therapies As part of their commitment, Bayer continues to invest in developing novel, patient-centric therapeutic approaches that reduce severity of disease and comorbidities International treatment guidelines incorporate the latest innovations in CAD and PAD care to reduce disease burden on patients and the healthcare system RELATED: VIDEO: Health Matters with Dr Adam Campaign Focus on Health and Wellness The World Health Organization estimated that cardiovascular diseases contribute to 40% of total adult mortality within the UAE. Two diseases of particular concern are coronary artery disease (CAD) and peripheral artery disease (PAD), both of which cause the narrowing of arteries supplying the organs and heart usually caused by atherosclerosis, implicating a very serious risk of heart attack or stroke Continue reading →

Medical marijuana, which refers to the use of the whole, unprocessed marijuana plant or its extracts for medicinal purposes, has generated a lot of excitement for its potential role in treating diseases ranging from anorexia to Alzheimers. While the plant has impressive medicinal properties that are still being explored, emerging research also suggests that frequentcannabis usemay be linked to heart risks, including an increased risk of heart attack and stroke. The findings highlight the need for increased research into the most effective dosages and routes of administration formedical marijuanawhile also pointing to potential dangers for frequent recreational users Continue reading →

Transparency Market Research (TMR) has published a new report titled, Cardiac Arrest Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027. According to the report, theglobalcardiac arrest treatment marketwas valued at US$ 2,650.0 Mn in 2018 and is projected to expand at a CAGR of 4.4% from 2019 to 2027 Continue reading →

Jing Tian,1 Jingjing Yan,2 Qing Zhang,1 Hong Yang,2 Xinlong Chen,1 Qiang Han,2 Rui Han,1 Jia Ren,1 Yanbo Zhang,2,3 Qinghua Han1 1Department of Cardiology, The 1st Hospital of Shanxi Medical University, Taiyuan, Shanxi Province 030001, Peoples Republic of China; 2Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi Province 030001, Peoples Republic of China; 3Shanxi Provincial Key Laboratory of Major Diseases Risk Assessment, Taiyuan, Shanxi Province 030001, Peoples Republic of China Correspondence: Qinghua HanDepartment of Cardiology, The 1st Hospital of Shanxi Medical University, 85 South Jiefang Road, Taiyuan, Shanxi Province 030001, Peoples Republic of ChinaTel +86 3100113031Fax +86 351 4867146Email syhqn@sohu.comYanbo ZhangDepartment of Health Statistics, School of Public Health, Shanxi Provincial Key Laboratory of Major Diseases Risk Assessment, Shanxi Medical University, 56 South XinJian Road, Taiyuan, Shanxi Province 030001, Peoples Republic of ChinaTel/fax +86 3543985051Email sxmuzyb@126.com Background: The re-hospitalization rate of patients with heart failure remains at a high level, and studies of the subject have focused mainly on event-time outcomes. Continue reading →

The market is estimated to grow with a CAGR of 9. 0% from 2019-2027. The growth of the market is driven by the factors such as rising cases of the chronic diseases such as heart and respiratory diseases and COPD and lung cancer among the countries such as UK and Germany among the other countries. Continue reading →